Previous 10 | Next 10 |
2023-04-05 10:07:20 ET Gainers: Liminal BioSciences ( LMNL ) +81% . InflaRx ( IFRX ) +51% . 180 Life Sciences ( ATNF ) +26% . YS Biopharma ( YS ) +22% . Immunic ( IMUX ) +21% . Losers: Bullfrog AI ( BFRG ) -15% ....
2023-04-05 08:13:52 ET Liminal BioSciences ( LMNL ) +89% c onfirms receipt of unsolicited non-binding transaction proposal. 180 Life Sciences ( ATNF ) +33% . Immunic ( IMUX ) +23% as imu-838 shows promise in ulcerative colitis trial. Freig...
180 Life Sciences (NASDAQ: ATNF) , a clinical-stage biotechnology company, will be participating at the Gordon Research Conference, which is slated for July 9–14, 2023. The presentation, which is titled “Physiological and Disease Relevance and Underlying Molecular Properties of Coll...
PALO ALTO, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that Professor Jagdeep Nanchahal has been selected to present at the Gordon Research Conference on “ Physiologic...
The U.S. Patent and Trademark Office (USPTO) issued a notice of allowance to 180 Life Sciences' ( NASDAQ: ATNF ) patent application related to treating Dupuytren's disease. The disorder is characterized by one or more fingers to bend toward the palm of the hand due to thicke...
180 Life Sciences ( NASDAQ: ATNF ) closed the recruitment of people with early stage Frozen shoulder in a trial in England after a government agency noted that the study was facing challenges. The company said the recruitment was being undertaken to decide the feasibility of cond...
PALO ALTO, Calif., Feb. 23, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that the United States Patent and Trademark Office (USPTO) has issued the Company a Notice of Allowance for United States...
PALO ALTO, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced closure to recruitment of men and women across England with early stage Frozen shoulder for a trial to determine the feas...
180 Life Sciences ( NASDAQ: ATNF ) is up 12% in Wednesday morning trading following the publication of a review on treatment for Dupuytren's disease that identified tumor necrosis factor as a potential target. The review also included results from a phase 2a dose ranging...
PALO ALTO, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘ Treatments for early stage Dupuytren’s disease: an evidence-based ...
News, Short Squeeze, Breakout and More Instantly...
180 Life Sciences Corp Com Company Name:
ATNF Stock Symbol:
NASDAQ Market:
180 Life Sciences Corp Com Website:
180 Life Sciences (NASDAQ: ATNF) today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “hearings panel”) of the Nasdaq Stock Market LLC that it has granted the company’s request for additional time to achieve compliance with Nasdaq’...
PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced that it received notice from the Nasdaq Listing Qualifications Panel (the “Hearings Panel”) of The Nasdaq S...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) rose 2.5% to $131.38 on volume of 280,159,738 shares Maxeon Solar Technologies Ltd. (MAXN) fell 8.1% to $0.248 on volume of 217,585,873 shares Tesla Inc. (TSLA) rose 3.7% to $262.33 on volume of 159,323,492 s...